tci Part B Insider - 2004 Issue 27

Inhalation Drugs: Prepare For Drastic Cuts To Albuterol And Ipratropium Reimbursement

Payments for nebulizer drugs were nebulous at best, OIG insistedMany physicians' offices, especially pulmonologists, have started providing nebulizer medications in recent years. But those drugs are about to move to bargain basement reimbursement levels.Inhalation drugs albuterol and ipratropium have long been on the top of the HHS Office of Inspector General's hit list, with 10 reports since February 1996 decrying high spending, and estimated $900 million in overspending in 2003 alone. The latest figures show that albuterol only cost suppliers 17  percent of the average wholesale price, and ipratropium cost 34   percent of AWP. Unless...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.